Difference between revisions of "Part:BBa K1189008:Experience"
Azzucoloto (Talk | contribs) |
Azzucoloto (Talk | contribs) |
||
Line 8: | Line 8: | ||
<img src="https://static.igem.org/mediawiki/2013/thumb/0/03/YYC2013_Blac_Amp_Survival_Assay_with_colonies.jpg/800px-YYC2013_Blac_Amp_Survival_Assay_with_colonies.jpg"> | <img src="https://static.igem.org/mediawiki/2013/thumb/0/03/YYC2013_Blac_Amp_Survival_Assay_with_colonies.jpg/800px-YYC2013_Blac_Amp_Survival_Assay_with_colonies.jpg"> | ||
<figcaption> | <figcaption> | ||
− | <p><b>Figure | + | <p><b>Figure 1. </b>Absorbance values at 600nm for each tube at four different time points: 0, 30, 60 and 120min. The cultures that expressed beta-lactamase (<a href="https://parts.igem.org/wiki/index.php?title=Part:BBa_K1189007"> |
<span class="Green"><b> | <span class="Green"><b> | ||
BBa_K1189007 | BBa_K1189007 | ||
Line 22: | Line 22: | ||
BBa_K1189031 | BBa_K1189031 | ||
</b></span> | </b></span> | ||
− | </a >) (Figure | + | </a >) (Figure 2) and we have demonstrated that beta-lactamase retained its enzymatic activity for both proteins. We repeated a variation of ampicillin survival assay where we pretreated LB containing ampicillin and chloramphenicol with our purified TALE A linked to beta-lactamase (<a href=" https://parts.igem.org/wiki/index.php?title=Part:BBa_K1189031"> |
<span class="Green"><b> | <span class="Green"><b> | ||
BBa_K1189031 | BBa_K1189031 | ||
Line 30: | Line 30: | ||
BBa_K1189031 | BBa_K1189031 | ||
</b></span> | </b></span> | ||
− | </a >), which means that we are expressing and purifying functional protein which is degrading the ampicillin (Figures | + | </a >), which means that we are expressing and purifying functional protein which is degrading the ampicillin (Figures 1 and 3). Figure 3 shows the OD at 24 hour time point from culturing where Figure 6 shows OD change over time. Both graphs show an increase in OD for cultures pre-treated with our protein demonstrating our protein is functional.</p> |
<figure> | <figure> | ||
− | <img src="https://static.igem.org/mediawiki/ | + | <img src="https://static.igem.org/mediawiki/parts/5/55/YYC2013_TALE_Blac_Western_Blot_White_Background.jpg"> |
<figcaption> | <figcaption> | ||
− | <p><b>Figure | + | <p><b>Figure 2. </b>On the left crude lysate of beta-lactamase + His (<a href="https://parts.igem.org/wiki/index.php?title=Part:BBa_K1189007"> |
<span class="Green"><b> | <span class="Green"><b> | ||
BBa_K1189007 | BBa_K1189007 | ||
Line 59: | Line 59: | ||
<img src="https://static.igem.org/mediawiki/2013/thumb/3/38/YYC2013_Blac_Amp_Survival_Assay_with_protein_24h.jpg/800px-YYC2013_Blac_Amp_Survival_Assay_with_protein_24h.jpg"> | <img src="https://static.igem.org/mediawiki/2013/thumb/3/38/YYC2013_Blac_Amp_Survival_Assay_with_protein_24h.jpg/800px-YYC2013_Blac_Amp_Survival_Assay_with_protein_24h.jpg"> | ||
<figcaption> | <figcaption> | ||
− | <p><b>Figure | + | <p><b>Figure 3. </b>Absorbance values at 600nm after 24h. Amounts from 0.1µg to 20µg of TALE A-link-Beta-lactamase (<a href=" https://parts.igem.org/wiki/index.php?title=Part:BBa_K1189031"> |
<span class="Green"><b> | <span class="Green"><b> | ||
BBa_K1189031 | BBa_K1189031 | ||
Line 68: | Line 68: | ||
<img src="https://static.igem.org/mediawiki/2013/thumb/d/de/YYC2013_Blac_Amp_Survival_Assay_with_protein_3_time_points.jpg/800px-YYC2013_Blac_Amp_Survival_Assay_with_protein_3_time_points.jpg"> | <img src="https://static.igem.org/mediawiki/2013/thumb/d/de/YYC2013_Blac_Amp_Survival_Assay_with_protein_3_time_points.jpg/800px-YYC2013_Blac_Amp_Survival_Assay_with_protein_3_time_points.jpg"> | ||
<figcaption> | <figcaption> | ||
− | <p><b>Figure | + | <p><b>Figure 4. </b>Absorbance values at 600nm in different time points. Amounts from 1.0µg to 10µg of TALE A-link-Beta-lactamase (<a href=" https://parts.igem.org/wiki/index.php?title=Part:BBa_K1189031"> |
<span class="Green"><b> | <span class="Green"><b> | ||
BBa_K1189031 | BBa_K1189031 | ||
Line 86: | Line 86: | ||
colourimetric assay | colourimetric assay | ||
</b></span> | </b></span> | ||
− | </a> using benzylpenicillin as our substrate. We were able to see a colour change from red to yellow. This is because there is phenol red, a pH indicator, added to the substrate solution. Beta-lactamase hydrolyzes benzylpenicillin to penicillinoic acid, which changes the pH of the solution from alkaline to acidic. This pH change causes the phenol red to change from red to yellow. Our negative controls, to which benzylpenicillin was not added, remained red. We can also see the colour change correlate to the amount of purified TALE A linked to beta-lactamase present in each sample (Figure | + | </a> using benzylpenicillin as our substrate. We were able to see a colour change from red to yellow. This is because there is phenol red, a pH indicator, added to the substrate solution. Beta-lactamase hydrolyzes benzylpenicillin to penicillinoic acid, which changes the pH of the solution from alkaline to acidic. This pH change causes the phenol red to change from red to yellow. Our negative controls, to which benzylpenicillin was not added, remained red. We can also see the colour change correlate to the amount of purified TALE A linked to beta-lactamase present in each sample (Figure 5).</p> |
<figure> | <figure> | ||
− | <img src="https://static.igem.org/mediawiki/ | + | <img src="https://static.igem.org/mediawiki/parts/5/5b/YYC2013_Blac_PenG_Assay.jpg"> |
<figcaption> | <figcaption> | ||
− | <p><b>Figure | + | <p><b>Figure 5. </b>Benzylpenicillin assay. On the top, the wells only had <a href="https://parts.igem.org/wiki/index.php?title=Part:BBa_K782004"> |
<span class="Green"><b> | <span class="Green"><b> | ||
TALE A | TALE A |
Revision as of 06:20, 28 September 2013
This experience page is provided so that any user may enter their experience using this part.
Please enter
how you used this part and how it worked out.
Applications of BBa_K1189008
User Reviews
UNIQ731e1a3663cc20ac-partinfo-00000001-QINU UNIQ731e1a3663cc20ac-partinfo-00000002-QINU